Demo Sign up Log In

Madrigal Pharmaceuticals Inc (MDGL)

Revenue

$1.43B

TTM · Period ending: Sep 30, 2026 · USD

MDGL Revenue

Latest reported$1.43Bperiod endingSep 30, 2026

Latest reported$1.43Bperiod endingSep 30, 2026

MDGL Revenue ($0.00 → $1.43B)

Annual revenue

High-resolution chart · PNG

MDGL revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Madrigal Pharmaceuticals Inc Revenue — Annual fiscal periods (USD)
Period ending	Revenue (USD)
Dec 31, 2025	958,403,000
Dec 31, 2024	180,133,000
Dec 31, 2023	0
Dec 31, 2022	0
Dec 31, 2021	0
Dec 31, 2020	0
Dec 31, 2019	0
Dec 31, 2018	0
Dec 31, 2017	0
Dec 31, 2016	0
Dec 31, 2015	0
Dec 31, 2014	0
Dec 31, 2013	0
Dec 31, 2012	0
Dec 31, 2011	7,584,000
Dec 31, 2010	14,803,000
Dec 31, 2009	144,245,000
Dec 31, 2008	2,615,000
Dec 31, 2007	743,000
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	173,000
Dec 31, 2003	1,304,000
Dec 31, 2002	0
Dec 31, 2001	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.